Ovarian Cancer

Study Finds Link Between Larger Endometriomas and Ovarian Cancer

January 9th 2021, 1:00am

Article

A study links the size of cysts associated with endometriosis with coexistent ovarian cancer.

Dr Bradley Monk Discusses Indications for PARP Inhibitors in Ovarian Cancer

December 30th 2020, 4:30pm

Video

Bradley Monk, MD, FACOG, FACS, clinician at Arizona Oncology, describes the current indications for PARP inhibitors in ovarian cancer.

Dr Bradley Monk on Response to PARP Inhibitors in Ovarian Cancer

December 28th 2020, 3:00pm

Video

Bradley Monk, MD, FACOG, FACS, clinician at Arizona Oncology, discusses the ovarian cancer patients most likely to respond well to PARP inhibition.

Dr Bradley Monk on the Changing Regulatory Landscape of PARP Inhibitors

December 26th 2020, 2:30pm

Video

Bradley Monk, MD, FACOG, FACS, a professor at the University of Arizona, chronicles the regulatory changes in PARP inhibitors as they gain more indications in ovarian cancer.

Dr Bradley Monk on Multidisciplinary Care With PARP Inhibitors

December 24th 2020, 4:00pm

Video

Bradley Monk, MD, FACOG, FACS, clinician at Arizona Oncology, shares his experience mitigating the potential side effects of PARP inhibitors in ovarian cancer treatment.

Dr Bradley Monk Discusses PARP Inhibitor Reimbursement

December 18th 2020, 6:30pm

Video

Bradley Monk, MD, FACOG, FACS, clinician at Arizona Oncology, professor at the University of Arizona and Creighton University in Phoenix, discusses the reimbursement of PARP inhibitors in ovarian cancer.

Novel Combination Shows Promise in Recurrent Ovarian Cancer

December 11th 2020, 6:45pm

Article

A combination of pembrolizumab with bevacizumab and cyclophosphamide showed clinical activity and tolerability in patients with recurrent ovarian cancer, a small study found.

Top-line Phase 1 Results for Cantrixil Confirm Earlier Efficacy, Safety Signals

December 10th 2020, 1:43pm

Article

Kazia Therapeutics will report the full results at a future scientific meeting.

Phase 1 Study of Novel Drug for Ovarian Cancer Shows Positive Results

December 5th 2020, 7:00pm

Article

One patient had a complete response and the majority of patients achieved disease control at 12 weeks.

Assisted Reproductive Technology Does Not Increase Ovarian Cancer Risk

December 4th 2020, 10:00pm

Article

New findings in Journal of the National Cancer Institute contradict previous research indicating that assisted reproductive technology might lead to an increased risk of ovarian cancer.